Ho Joon Im
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Evaluation of Treatment Efficacy According to Risk Group in Relapsed Childhood Acute Lymphoblastic Leukemia (NCT05827549) | Ho Joon Im | 2024-04-04 |
Track Ho Joon Im automatically
Every clearance here is in the API, with alerts when new ones post.